PTAB Denies Another Kyle Bass Petition For Drug Review
The Patent Trial and Appeal Board has denied another petition by an organization tied to hedge fund manager Kyle Bass for an inter partes review of a patent on Pharmacyclics Inc.'s...To view the full article, register now.
Already a subscriber? Click here to view full article